BioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Large Increase in Short Interest

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 99,700 shares, an increase of 129.7% from the March 31st total of 43,400 shares. Based on an average trading volume of 1,510,000 shares, the short-interest ratio is currently 0.1 days. Approximately 1.4% of the company’s stock are sold short.

BioNexus Gene Lab Stock Performance

Shares of NASDAQ BGLC remained flat at $0.59 during mid-day trading on Friday. 37,932 shares of the stock were exchanged, compared to its average volume of 287,578. BioNexus Gene Lab has a 1-year low of $0.31 and a 1-year high of $17.88. The stock has a fifty day simple moving average of $0.72 and a 200 day simple moving average of $0.61.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments.